- Home
- SRTS vs RENB Comparison
SRTS vs RENB Comparison
Compare SRTS & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- RENB
- Stock Information
- Founded
- SRTS 2010
- RENB 2011
- Country
- SRTS United States
- RENB United States
- Employees
- SRTS N/A
- RENB N/A
- Industry
- SRTS Medical/Dental Instruments
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- RENB Health Care
- Exchange
- SRTS Nasdaq
- RENB Nasdaq
- Market Cap
- SRTS 51.8M
- RENB 57.7M
- IPO Year
- SRTS 2016
- RENB N/A
- Fundamental
- Price
- SRTS $3.15
- RENB $0.16
- Analyst Decision
- SRTS Strong Buy
- RENB
- Analyst Count
- SRTS 3
- RENB 0
- Target Price
- SRTS $8.00
- RENB N/A
- AVG Volume (30 Days)
- SRTS 84.7K
- RENB 1.2M
- Earning Date
- SRTS 11-13-2025
- RENB 11-13-2025
- Dividend Yield
- SRTS N/A
- RENB N/A
- EPS Growth
- SRTS N/A
- RENB N/A
- EPS
- SRTS N/A
- RENB N/A
- Revenue
- SRTS $37,564,000.00
- RENB N/A
- Revenue This Year
- SRTS N/A
- RENB N/A
- Revenue Next Year
- SRTS $46.14
- RENB N/A
- P/E Ratio
- SRTS N/A
- RENB N/A
- Revenue Growth
- SRTS 3.29
- RENB N/A
- 52 Week Low
- SRTS $3.03
- RENB $0.16
- 52 Week High
- SRTS $9.33
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- SRTS 37.43
- RENB 29.75
- Support Level
- SRTS $3.09
- RENB $0.18
- Resistance Level
- SRTS $3.29
- RENB $0.22
- Average True Range (ATR)
- SRTS 0.11
- RENB 0.02
- MACD
- SRTS 0.04
- RENB -0.00
- Stochastic Oscillator
- SRTS 15.38
- RENB 1.54
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.